SCHEMBL28465490

SCHEMBL28465490

Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(CCC(C)N3CCOCC3)c3ccccc23)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.76
MAPK12 P53778 6/20 0.64
TNF P01375 6/20 0.64
MAPK13 O15264 3/20 0.64
MAPK11 Q15759 3/20 0.64
HCK P08631 3/20 0.64
ABL1 P00519 2/20 0.64
RAF1 P04049 2/20 0.64
LYN P07948 2/20 0.64
SRC P12931 2/20 0.64
MAPK9 P45984 2/20 0.64
DDR2 Q16832 2/20 0.64
CIT O14578 1/20 0.64
MUSK O15146 1/20 0.64
MAP3K7 O43318 1/20 0.64
RIPK2 O43353 1/20 0.64
STK10 O94804 1/20 0.64
MAP4K4 O95819 1/20 0.64
CHEK2 O96017 1/20 0.64
EGFR P00533 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29593598 0.86 MAPK14 (1.00) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL28468353 0.86 MAPK14 (0.78) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL294394 0.86 MAPK14 (1.00) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL295639 0.86 MAPK14 (0.82) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL29593440 0.86 MAPK14 (0.82) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL29593381 0.86 MAPK14 (0.76) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL20876925 0.86 MAPK14 (0.76) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL296487 0.86 MAPK14 (0.76) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL30335874 0.83 MAPK14 (0.65) MAPK14MAPK12TNFMAPK13MAPK11
SCHEMBL295782 0.83 MAPK14 (0.65) MAPK14MAPK12TNFMAPK13MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-09-24 CN disclosed
CN-114732910-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-08-23 CN disclosed
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed
CN-111601593-B P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-04-15 CN disclosed
CN-111601593-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2020-08-28 CN disclosed